Kiran Mazumdar-Shaw, managing director and co-founder of Biocon (Samyukta Lakshmi/Bloomberg via Getty Images)
Malaysian government enlists native Biocon for insulin supply deal
Malaysia’s largest biopharma has landed a three-year contract with the government to manufacture and supply the country with insulin.
Biocon Biologics will make and supply Insugen to the Ministry of Health. The contract is valued at $90 million, Biocon said in a press release. With the deal, Insugen will be available to patients at the Ministry of Health hospitals, district health offices and health clinics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
